Efficacy and safety of topical steroids in paediatric atopic dermatitis

Journal of the European Academy of Dermatology and Venereology

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Lane, Alfred T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mometasone furoate; Paediatric atopic dermatitis; Topical corticosteroids

Indexed keywords

ALCLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE; HYDROCORTISONE; MOMETASONE FUROATE;

ADRENAL SUPPRESSION; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; GROWTH RETARDATION; HUMAN; LIVER METABOLISM; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0030872025     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(97)90020-9     Document Type: Article

References (15)

1. Lapidus CS, Schwartz DF, Honig PJ. Atopic dermatitis in children: WHO cares? Who pays? J Am Acad Dermatol 1993;28:699-703.
2. Kay J, Gawkroder DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994;30:35-39.
3. Sampson HA. Atopic dermatitis. Ann Allergy 1992;69:469-479.
4. Williams HC, Burney PG, Hay RJ et al. The UK working party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131:383-396.
5. Williams HC, Burney PG, Strachan D, Hay RJ. The UK working party's diagnostic criteria for atopic dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994;131:397-405.
6. Williams HC, Bumey PG, Pembroke AC, Hay RJ. The UK working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131:406-416.
7. Yohn JJ, Weston WL. Topical glucocorticoids. In Weston WL, ed. Current Problems in Dermatology. Chicago: Year Book Medical Publishers, 1990;11:34-63.
8. Hepburn D, Yohn JJ, Weston WL. Topical steroid treatment in infants, children and adolescents. Adv Dermatol 1994;9:225-255.
9. Vernon HJ, Lane AT, Weston W. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. J Am Acad Dermatol 1991;24:603-607.
10. Samson C, Peets E, Winter-Sperry R, Wolkoff H. Mometasone furoate - Elocon® - a medium potency topical corticosteroid with favorable efficacy/safety profile. In Maibach HI, Surber C, eds. Topical Corticosteroids. Basel: Karger, 1992;462-479.
11. Bressinck R, Williams J, Peets E. Comparison of the effect of mometasone furoate ointment 0.1%, and hydrocortisone ointment 0.1%, on adrenocortical function in psoriasis patients. Today Ther Trends 1988;5:25-35.
12. Viglioglia P, Jones ML, Peets EA. Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses. J Int Med Res 1990;18:460-467.
13. Lane AT, Prose NS, Rehder PA et al. Comparison of once-daily mometasone furoate cream 0.1%, twice-daily hydrocortisone cream 2.5%, and twice-daily alclometasone dipropionate cream in the treatment of pediatric patients with atopic dermatitis. Pediatr Dermatol 1997, in press.
14. Bleehan SS, Chu AC, Hamann I et al. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 1995;133:592-597.
15. Watsky KL, Freije L, Leneveu M-C, Wenck HA, Lefell DJ. Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis 1992;50:383-386.